Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
(NASDAQ: VRDN) Delayed: 22.44 --0 (-0%)
Previous Close $22.44    52 Week High
Open $22.44    52 Week Low
Day High $22.44    P/E N/A 
Day Low $22.44    EPS
Volume 3,854